論文與著作

Yi-Chen Su, Legislative preparedness for the control of pandemics – using Taiwan as an example, Medico-Legal Journal 89(1): 19-22 (2021).

The Extent of Harm to the Victim as an Alternative Aggravating Factor for the Conviction of Felony Fraud in the Context of Food-Safety Violations, 71 Food & Drug L.J. 658 (2016) (SSCI).

Advanced Maternal Age in the Shadow of Confucianism, American J. of Bioethics 15(11):54-56 (2015) (SSCI, IF=5.288, ethics 1/52).

High-Income Countries' Corresponding Obligation Not To Exploit Non-Nationals, American Journal of Bioethics 14(5):42-44 (2014) (SSCI, IF=5.288, Ethics 1/52).

When Ethical Reform Became Law: Constitutional Concerns Raised by Recent Legislation in Taiwan, J. of Medical Ethics 40(7): 484-487 (2014) (SSCI, IF=1.419, ethics 9/48).

Lost in Interpretation: Solving the Myth of Diagnostic Method Patents, 7 Asian J. of WTO & International Health Law and Policy 377-98 (2012) (SSCI)

Multiple Facets of Damage Caused by the Exposure to Low-Dose Radiation and the Legal Remedy, 19:2 Buffalo Environmental Law J. 301 (2012), first author, co-written with Peter W.S. Chang.

What about Know-How: Heightened Obviousness and Lowered Disclosure Is Not a Panacea to the American Patent System for Biotechnological Medication and Pharmaceutical Inventions in the Post-KSR Era, 14:2 Marquette I.P. Law Review 321 (2010); cited by 9 law professors in the amicus brief filed in September 2011 for Mayo v. Prometheus in the U.S. Supreme Court; cited in the American Jurisprudence Proof of Facts 3d (2012); excerpted in Goldstein & Trimble, International Intellectual Property Law: Cases and Materials, 449-454 (3^rd ed. 2012).

Revisiting Factor VIII Cases: Is It Time for an Agency Adjudication System?, 63 Food & Drug L.J. 943 (2008). (SSCI) (SCI)

Mary Doe’s Destiny: How the United States Has Banned Human Embryonic-Stem-Cell Research In the Absence of a Direct Prohibition, 14 Richmond J.L. & Tech. 12 (2008), first author, co-written with Albert Wai-Kit Chan; selected by the Rutgers Computer & Technology Law Journal as one of the most important and timely articles under the category of "biotechnology and pharmaceuticals" in 2008.

Too Costly to Defend: Who Is Benefited from the U.S. Supreme Court’s Recent Holdings Concerning Biotechnology Patent Disputes?, 18 Albany L.J. of Science & Tech. 53 (2008), first author, co-written with Albert Wai-Kit Chan; selected by the Rutgers Computer & Technology Law Journal as one of the most important and timely articles under the category of "biotech patent" in 2008.

The Queens Drug and Mental Health Court in New York City: an Example in Shaping the Interface Between the Mental Health System and the Criminal Justice System, Soochow L.J. 4(2): 83 (2007) (Taiwan).

High Doses of Acetaminophen Elevate the Hepatic Levels of Superoxide Dismutase and Catalase in Mice, The Chinese Pharmaceutical Journal 47:6, 555-565 (1996), first author, co-written with 董一致, 許世賢, 林松洲, and 陳建志.

Simple Colorimetric Method for the Assessment of Aniline Exposure-Analysis of Urinary P-aminophenol, B. Environ. Contam. Toxicol. 49:694-700 (1992) (SCI), co-written with 張吳名任(Ming J. W. Chang) and 林瑞雄(Ruey S. Lin)； 謹紀念最敬愛的張吳老師。

陳桂恒&蘇宜成，生技醫藥研發成果商業化理論與實務：技術、法規、智財、商業及策略評估 (華泰文化).

蘇宜成，智慧財產授權與評價探討 (國立中興大學出版中心/元照出版編印)

Paving the Way to a Harmonized Legal Platform for the Sharing of Human-Biobank Data beyond European Borders, session speaker, Medial Ethics Conference, Uppsala Universitet (Uppsala, Sweden, Jun. 15, 2010).

從美國孟山都(Monsanto)系列訴訟探討農技智財保護策略與趨勢，2012年生物科技與法律研討會，國立中興大學 (Oct. 26, 2012).

制度錯了 學生自救有方，師友月刊 No. 554 (2013.08) pp. 15-19 (主編約稿)

[教育] 學用落差 大學生也要負責，中國時報2013-02-18

[商標法] MISS WU登國際 台灣刁難...，聯合報 2013-01-23

[專利法] 設境外平台 拚國際專利，中國時報 2013-01-21

[司法] 不信任司法 卻支持死刑，中國時報2013-01-05

[生醫倫理] 生命倫理向易死難生傾斜？中國時報 2012-12-28

[專利法] 專利布局 需跨領域人才，中國時報 2012-12-20

[生醫科技法] 人體資料庫管理的公衛隱憂，中國時報 2010-06-14

[著作權法] 相似不等於侵權，自由時報 2010-05-11